Research programme: viral vaccines - Mymetics

Drug Profile

Research programme: viral vaccines - Mymetics

Alternative Names: Chikungunya virus infections - Mymetics; RSV vaccine - Mymetics; Zika virus infection - Mymetics

Latest Information Update: 16 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Mymetics Corporation
  • Class
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Research Chikungunya virus infections; Zika virus infection
  • No development reported Respiratory syncytial virus infections

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Respiratory-syncytial-virus-infections in Netherlands
  • 28 Jan 2016 Early research in Chikungunya virus infections in Netherlands (unspecified route)
  • 28 Jan 2016 Early research in Zika virus infection in Netherlands (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top